Robert M. Greene

Dr. Robert M. Greene


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2010 in Birth Defects Research Part C: Embryo Today: Reviews
Verified
Journal Article
Closed access
PDF file
RGRobert M. Greene
Robert M. Greene
MPM. Michele Pisano
M. Michele Pisano

8 January 2013 in Source Code for Biology and Medicine
Verified
Journal Article
Open access
PDF file
GBGuy Brock
Guy Brock
PMPartha Mukhopadhyay
Partha Mukhopadhyay
VPVasyl Pihur
Vasyl Pihur
CWCynthia Webb
Cynthia Webb
RGRobert M. Greene
Robert M. Greene
MPM Michele Pisano
M Michele Pisano
MicroRNAs (miRNAs) constitute the largest family of noncoding RNAs involved in gene silencing and represent critical regulators of cell and tissue differentiation. Microarray expression profiling of miRNAs is an effective means of acquiring genome-level information of miRNA activation and inhibition, as well as the potential regulatory role that these genes play within a biological system. As with mRNA expression profiling arrays, miRNA microarrays come in a variety of platforms from numerous manufacturers, and there are a multitude of techniques available for reducing and analyzing these data.

9 August 2019 in Birth Defects Research
Verified
Journal Article
Closed access
RGRobert M. Greene
Robert M. Greene
MPM. Michele Pisano
M. Michele Pisano

1 January 2009 in The International Journal of Developmental Biology
Verified
Journal Article
Open access
PDF file
VBVasker Bhattacherjee
Vasker Bhattacherjee
KHKristin H. Horn
Kristin H. Horn
SSSaurabh Singh
Saurabh Singh
CWCynthia L. Webb
Cynthia L. Webb
MPM. Michele Pisano
M. Michele Pisano
RGRobert M. Greene
Robert M. Greene
Mutations in each of the transcriptional co-activator genes - CBP, p300, Cited2, Cart1 and Carm1 - result in neural tube defects in mice. The present study thus furnishes a complete and comparative temporal and spatial expression map of CBP/p300 and associated transcriptional co-activators, Cited2, Cart1 and Carm1 during the period of murine neural tube development (embryonic days 8.5 to 10.5). Each co-activator except Cart1 was expressed in the dorsal neural folds on E8.5. Although CBP and p300 are functionally interchangeable in vitro, their respective expression patterns diverge during embryogenesis before neural fold fusion is complete. CBP gene expression was lost from the neural folds by E8.75 and was thereafter weakly expressed in the maxillary region and limb buds, while p300 exhibited strong expression in the first branchial arch, limb bud and telencephalic regions on E9.5. Cart1 exhibited strong expression in the forebrain mesenchyme from E9.0 through E10.5. Although CBP, p300, Carm1 and Cited2 share temporal expression on E8.5, these co-activators have different spatial expression in mesenchyme and/or the neuroepithelium. Nevertheless, co-localization to the dorsal neural folds on E8.5 suggests a functional role in elevation and/or fusion of the neural folds. Target genes, and pathways that promote cranial neural tube fusion that are activated by CBP/p300/Carm1/Cited2/Cart1-containing transcriptional complexes await elucidation.

5 December 2009 in Reproductive Toxicology
Verified
Journal Article
Closed access
PMPartha Mukhopadhyay
Partha Mukhopadhyay
KHKristin H. Horn
Kristin H. Horn
RGRobert M. Greene
Robert M. Greene
MPM. Michele Pisano
M. Michele Pisano

18 July 2011 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
PMPartha Mukhopadhyay
Partha Mukhopadhyay
GBGuy Brock
Guy Brock
SASavitri Appana
Savitri Appana
CWCynthia Webb
Cynthia Webb
RGRobert M. Greene
Robert M. Greene
MPM. Michele Pisano
M. Michele Pisano